ImmunoPrecise Antibodies Ltd.

TSXV:IPA Rapport sur les actions

Capitalisation boursière : CA$162.1m

This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

ImmunoPrecise Antibodies Gestion

Gestion contrôle des critères 2/4

Informations clés

Jennifer Bath

Directeur général

CA$1.9m

Rémunération totale

Pourcentage du salaire du PDG34.9%
Durée du mandat du directeur général4.8yrs
Propriété du PDG0.4%
Durée moyenne d'occupation des postes de direction1.3yrs
Durée moyenne du mandat des membres du conseil d'administration4.5yrs

Mises à jour récentes de la gestion

Recent updates

We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Oct 20
We Think ImmunoPrecise Antibodies (CVE:IPA) Needs To Drive Business Growth Carefully

Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Dec 23
Earnings Update: ImmunoPrecise Antibodies Ltd. (CVE:IPA) Just Reported And Analysts Are Boosting Their Estimates

Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Nov 25
Is ImmunoPrecise Antibodies (CVE:IPA) Using Debt In A Risky Way?

Analyse de la rémunération des PDG

Comment la rémunération de Jennifer Bath a-t-elle évolué par rapport aux bénéfices de ImmunoPrecise Antibodies?
DateRémunération totaleSalaireBénéfices de l'entreprise
Jul 31 2022n/an/a

-CA$23m

Apr 30 2022CA$2mCA$649k

-CA$17m

Jan 31 2022n/an/a

-CA$17m

Oct 31 2021n/an/a

-CA$15m

Jul 31 2021n/an/a

-CA$10m

Apr 30 2021CA$2mCA$503k

-CA$7m

Jan 31 2021n/an/a

-CA$3m

Oct 31 2020n/an/a

-CA$3m

Jul 31 2020n/an/a

-CA$3m

Apr 30 2020CA$673kCA$488k

-CA$5m

Jan 31 2020n/an/a

-CA$8m

Oct 31 2019n/an/a

-CA$8m

Jul 31 2019n/an/a

-CA$9m

Apr 30 2019CA$1mCA$505k

-CA$8m

Jan 31 2019n/an/a

-CA$6m

Oct 31 2018n/an/a

-CA$6m

Jul 31 2018n/an/a

-CA$5m

Apr 30 2018CA$65kCA$65k

-CA$5m

Rémunération vs marché: Jennifer's total compensation ($USD1.39M) is above average for companies of similar size in the Canadian market ($USD178.89K).

Rémunération et revenus: Jennifer's compensation has been consistent with company performance over the past year.


PDG

Jennifer Bath

4.8yrs

Titularisation

CA$1,856,482

Compensation

Dr. Jennifer Lynne Bath, Ph D, has been the Chief Executive Officer and President of ImmunoPrecise Antibodies Ltd. since February 21, 2018.Dr. Bath served as the Global Director of Client Relations at Ald...


Équipe de direction

NomPositionTitularisationCompensationPropriété
Jennifer Bath
CEO, President & Non-Independent Director4.8yrsCA$1.86m0.44%
CA$ 707.3k
Brad McConn
Chief Financial Officerless than a yearCA$432.71k0.032%
CA$ 52.0k
Ilse Roodink
Chief Scientific Officer1.3yrsCA$514.16k0.013%
CA$ 21.7k
David Orton
Chief Operating Officer5.7yrspas de donnéespas de données
Carla Dahl
Vice President of Marketing1.3yrspas de données0.040%
CA$ 65.0k
Barry Duplantis
Vice President of Client Relationsno datapas de données0.0048%
CA$ 7.8k

1.3yrs

Durée moyenne de l'emploi

Gestion expérimentée: IPA's management team is not considered experienced ( 1.3 years average tenure), which suggests a new team.


Membres du conseil d'administration

NomPositionTitularisationCompensationPropriété
Jennifer Bath
CEO, President & Non-Independent Director4.5yrsCA$1.86m0.44%
CA$ 707.3k
James Kuo
Independent Chairman of the Board5.9yrsCA$130.84k0.10%
CA$ 162.5k
Gregory Smith
Independent Director6.2yrsCA$95.66k0.17%
CA$ 282.7k
Guy Champagne
Member of Advisory Board4.3yrsCA$55.00kpas de données
Robert Burke
Independent Director4.9yrsCA$87.99k0.12%
CA$ 201.5k
Dion Neame
Member of Strategic Advisory Board1.5yrspas de donnéespas de données
Anna Pettersson
Independent Directorless than a yearCA$75.55kpas de données

4.5yrs

Durée moyenne de l'emploi

57yo

Âge moyen

Conseil d'administration expérimenté: IPA's board of directors are considered experienced (4.5 years average tenure).